KMT2A and leukemia: Studies on cell lines RS4-11 (MLL-AF4+ B-ALL), Nalm-6 (non-MLL-r B-ALL), and MOLM-13 (MLL-AF9+ AML) show the melatonin-induced suppression of mixed lineage leukemia (MLL).